In Brief: Chiron/Ortho v. International Murex
This article was originally published in The Gray Sheet
Executive Summary
Chiron/Ortho v. International Murex: U.K. Court of Appeals rules that the Hepatitis C (HCV) immunoassay tests manufactured by Murex Diagnostics Ltd. and United Biomedical Inc. (UBI) infringe primary claims relating to Chiron's U.K. HCV patent, No. GB 2,212,511. The court made its decision after Chiron re-amended its HCV patent by deleting claims that cover non-HCV products; the ruling confirms that Murex and UBI still infringe the re-amended patent. Murex says it will continue to challenge Chiron and Ortho's "anti-competitive domination" of the HCV market by requesting a review of the situation from the European Commission. A trial is scheduled to begin in July of 1996 to determine the amount of damages to be assessed against Murex and UBI...